Outset Medical (OM) revenue and earnings history
Outset Medical reported revenue of $119M for fiscal 2025 (year ended Dec 31, 2025), +5.1% on the year before, and net income of −$81.7M.
Over 7 years, from fiscal 2018 to fiscal 2025, revenue grew at a compound rate of +79.3% a year.
Revenue and net income, 8 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $119M+5.1% | −$66.7M | −$81.7M | −$46.3M | $798K | −$47.1M | $15.6M | — | — | $35M | $96.2M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Outset Medical (OM) on OQRO.
Common questions
What was Outset Medical's revenue in fiscal 2025?
$119M for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 13, 2026. That is +5.1% on fiscal 2024 ($114M).
How fast has Outset Medical's revenue grown?
From $2.01M in fiscal 2018 to $119M in fiscal 2025: a compound annual growth rate of +79.3% over 7 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Outset Medical been profitable?
Where these figures come from
The SEC’s companyfacts data: every figure Outset Medical tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
